Marquette Asset Management LLC purchased a new position in shares of Rain Oncology Inc. (NASDAQ:RAIN – Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 84,135 shares of the company’s stock, valued at approximately $73,000. Marquette Asset Management LLC owned 0.23% of […]
Shares of Rain Oncology Inc. (NASDAQ:RAIN – Get Free Report) have been assigned a consensus rating of “Hold” from the twelve ratings firms that are covering the firm, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average […]
Rain Oncology Inc. (NASDAQ:RAIN – Get Free Report) has earned an average recommendation of “Hold” from the twelve analysts that are presently covering the stock, Marketbeat reports. Ten research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among brokerages […]
Rain Oncology Inc. (NASDAQ:RAIN – Get Free Report) major shareholder Kevin C. Tang acquired 131,631 shares of the company’s stock in a transaction dated Friday, October 13th. The shares were bought at an average price of $0.99 per share, for a total transaction of $130,314.69. Following the acquisition, the insider now owns 4,024,486 shares in […]
Rain Oncology Inc. (NASDAQ:RAIN – Get Free Report) was the target of a significant drop in short interest during the month of September. As of September 15th, there was short interest totalling 705,700 shares, a drop of 18.1% from the August 31st total of 861,800 shares. Currently, 3.5% of the company’s shares are sold short. […]